semaglutide and sermorelin taken together vs semaglutide: which peptide matches your goals A Scientific Look at Combining

Contraindications Based on mechanism of action and conservative interpretation of potential risks, BPC-157 use is generally discouraged in individuals with active or recent cancer, pregnancy or breastfeeding, autoimmune conditions with active flares, children and adolescents (unknown effects on development), and known hypersensitivity to any peptide compounds

It's that stimulating the same brain regions these drugs act on produced a comparable metabolic effect with only five weeks of treatment and no ongoing medication

For patients focused on body composition (building lean mass while reducing body fat), some providers recommend pairing IGF-1 LR3 with a GLP-1 microdose protocol

Look for board-certified doctors, nurse practitioners, or physician assistants who specialize in weight management or hormone health